R&D Systems Recombinant Human ERO1L alpha Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Applications: Enzyme Activity
Manufacturer: R&D Systems 9855EO020
DescriptionThe Recombinant Human ERO1L alpha Protein is derived from T. ni (baculovirus). The Recombinant Human ERO1L alpha Protein has been validated for the following applications: Enzyme Activity.
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.|
|<0.10 EU per 1 μg of the protein by the LAL method.|
|Supplied as a 0.2 μm filtered solution in Tris, NaCl and TCEP.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.|
|T. ni (baculovirus)|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok